Search

ISSN: 2228-5881 eISSN: 2251-7308

2024, Vol 14, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin

Shamsi Naderi Beni, Shirin Kouhpayeh, Zahra Hejazi, Nahid Heidari Hafshejani, Hossein Khanahmad*

Adv Pharm Bull. 2015;5(3): 429-434. doi: 10.15171/apb.2015.058

PMCID: PMC4616894 PMID: 26504766 Scopus ID: 84983574230

Article

PDF

XML

Cited By:

7

4

4

Research Article

2. Preparation and Statistical Modeling of Solid Lipid Nanoparticles of Dimethyl Fumarate for Better Management of Multiple Sclerosis

Smriti Ojha*, Babita Kumar

Adv Pharm Bull. 2018;8(2): 225-233. doi: 10.15171/apb.2018.027

PMCID: PMC6046417 PMID: 30023324 Scopus ID: 85048861588

Article

PDF

XML

Cited By:

13

4

15

Review Article

3. A Review of Herbal Therapy in Multiple Sclerosis

Sina Mojaverrostami* , Maryam Nazm Bojnordi, Maryam Ghasemi-Kasman , Mohammad Ali Ebrahimzadeh , Hatef Ghasemi Hamidabadi

Adv Pharm Bull. 2018;8(4): 575-590. doi: 10.15171/apb.2018.066

PMCID: PMC6311642 PMID: 30607330 Scopus ID: 85057728103

Article

PDF

XML

Cited By:

32

20

39

Research Article

4. Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis

Mehrdad Gholamzad , Hussein Baharlooi , Mehdi Shafiee Ardestani, Zeinab Seyedkhan, Maryam Azimi*

Adv Pharm Bull. 2021;11(3): 505-513. doi: 10.34172/apb.2021.058

PMCID: PMC8421634 PMID: 34513625 Scopus ID: 85108911841

Article

PDF

Full Text

XML

Cited By:

3

1

4

Mini Review

5. Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect

Anjali Kandiruthi Ravi , Saradhadevi Kuppusami Muthukrishnan*

Adv Pharm Bull. 2022;12(3): 515-523. doi: 10.34172/apb.2022.057

PMCID: PMC9348531 PMID: 35935051 Scopus ID: 85140274831

Article

PDF

Full Text

XML

Cited By:

0

0

1

Research Article

6. Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

Ali Akbar Alizadeh , Behzad Jafari, Siavoush Dastmalchi*

Adv Pharm Bull. 2023;13(1): 113-122. doi: 10.34172/apb.2023.012

PMCID: PMC9871275 PMID: 36721815

Article

PDF

Full Text

XML

Cited By:

0

1

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank